FUJIFILM Healthcare Americas, a provider of endoscopy and endosurgery solutions, has partnered with EndoSim, a company specializing in endoscopic simulation, to expand access to EndoGel, a training model that simulates human tissue to help endoscopists practice endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM) procedures. Through this partnership, Fujifilm will transfer its exclusive U.S. distributorship of EndoGel to EndoSim, expanding access of this critical training tool to the full market.
Fujifilm identified a training gap in the U.S. market for ESD and POEM procedures, which are cutting-edge and lifesaving minimally invasive endoscopic surgical procedure more widely in Asian healthcare markets. This gap stemmed from a lack of practice material (aside from living tissue, animal tissue, and cadaver tissue) to train on highly technically complex procedure methods, leading the company to explore other options and ultimately bring EndoGel to the U.S. market in July 2022.
EndoGel addresses this problem by simulating the texture of human tissue involved in ESD and POEM procedures, providing clinicians with a life-like simulation experience. With this unique and innovative training model, endoscopy professionals can benefit from the ability to:
- practice marking and injecting,
- perform circumferential incisions,
- perform submucosal dissection, myotomy and clipping
